Aug. 21, 2012 Promising
results were reported today from a proof-of-concept clinical trial
of an anti-hunger ingredient for yogurt, fruit shakes,
smoothies and other foods that would make people feel full longer
and ease the craving to eat. Scientists described the ingredient,
a new version of a food additive that has been in use for more
than 50 years, at the 244th National Meeting & Exposition
of the American Chemical Society.
The potential new tool in the
battle of the bulge is methyl cellulose, a white powder that dissolves
in cold water to form a thick solution that turns into a gel
or gelatin-like material upon heating. Methyl cellulose already
provides a pleasant texture and holds together the ingredients
in hundreds of food products like baked goods, sweet and savory
snacks and ready meals.
Carsten Huettermann, Ph.D., who
presented the report, said that this is the first use of methyl
cellulose as a satiety ingredient in food.
This ingredient would make
people feel full after eating smaller amounts of food, Huettermann
explained. With that sense of fullness and hunger-satisfaction,
they would not crave more food. In our first study, we saw that
fewer calories were consumed at the following meal after eating
our new product. Our next step now is to investigate in further
studies the mechanism of action and whether this may have an impact
on weight management.
The updated methyl cellulose,
named SATISFIT-LTG, showed promise for doing that in a controlled
clinical trial that Huettermann discussed at the meeting. He is
with Dow Wolff Cellulosics in Bomlitz, Germany, which manufactures
methyl cellulose. Volunteers who consumed SATISFIT-LTG experienced
a reduction in the sensation of hunger that lasted until the consumption
of a following meal in which the volunteers could eat as much
as they wanted (two hours after eating SATISFIT-LTG) and a statistically
significant reduced intake of calories at this meal. The consumption
of SATISFIT-LTG resulted in a 13 percent decrease in calorie intake.
Huettermann explained that conventional
versions of methyl cellulose pass through the stomach rapidly
and do not work as a satiety ingredient. SATISFIT-LTG, however,
forms a gel at body temperature, and the gel lingers in the stomach
before passing into the small intestine.
The scientists are developing
SATISFIT-LTG as a potential ingredient in cold foods, such as
smoothies and yogurts, and Huettermann said that work will continue
based on the promising clinical trial results.
April 28th - Gastric
bypass cuts death risk:
Obese people who undergo gastric bypass surgery are less likely
to die from heart attack and stroke than people who receive more
conventional treatment for their weight condition..
A University of Gothenburg, Sweden, study, published in the Journal
of the American Medical Association, included about 4,000 patients
in Sweden who were recruited between 1987 and 2001.
The surgery patients either had gastric bypass (13.2 percent),
banding (18.7 percent), or vertical banded gastroplasty (68.1
percent), and all lost 16-23 percent of their body weight in subsequent
years.
A control group did not have any type of surgery and showed a
0 to 1 percent weight loss at follow-up periods of 2, 10, 15 and
20 years.
Bariatric surgery was associated
with reduced number of fatal heart attack deaths (22 in the surgery
group vs. 37 in the control group. It was also linked to a lower
number of heart attacks overall, fewer strokes, and fewer fatal
strokes.
But when the researchers looked at weight change alone, they could
find no significant relationship to cardiovascular events in either
group, suggesting that the weight loss itself might not be the
driver of fewer deaths.
There are many benefits to bariatric surgery and some of these
benefits are independent of the degree of the surgically induced
weight loss, the study concluded.
Other studies have shown that the benefits of gastric surgery
for extremely obese people can include long-term changes of body
weight, better quality of life, and fewer incidences of diabetes
and cancer.
The most common type of surgery in the study, vertical banded
gastroplasty, has been replaced by newer methods that are even
more effective, so the cardiovascular death risk is likely even
lower today.
Almost 200,000 gastric bypass operations, in which the stomach
is sectioned off so that the smaller amounts of food can fit inside,
are done annually in the United States.